Trademark Overview
On Monday, April 22, 2024, a trademark application was filed for OBARIS with the United States Patent and Trademark Office. The USPTO has given the OBARIS trademark a serial number of 79398667. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Monday, May 12, 2025. This trademark is owned by OBaris AG. The OBARIS trademark is filed in the Advertising, Business and Retail Services, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:
Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; veterinary preparations for companion and livestock animals for the treatment of metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, respiratory, gastrointestinal, oncological, hepatological, ophthalmic, dermatological, neurological, and immune system-related conditions; sanitary preparations for medical purposes; dietetic foods adapted for medical and veterinary purposes; food for babies; dietary supplements for humans and animals; medical plasters, medical dressings; material for dental fillings and dental impressions; disinfectants; preparations for destroying vermin; fungicides; herbicides.
Advertising services; business management; business organization consulting; business administration; providing office functions.
Scientific and technological services and research and design in the field of pharmaceuticals, medical devices, and biopharmaceuticals; industrial analysis consultation; industrial research in the field of pharmaceuticals, medical devices, and biopharmaceuticals; industrial design services; quality control of services; authentication of data in the field of pharmaceuticals, medical devices, and biopharmaceuticals.
